BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 26421710)

  • 21. Identification of Breast Cancer Stem Cells Using a Newly Developed Long-acting Fluorescence Probe, C5S-A, Targeting ALDH1A1.
    Okamoto A; Funakoshi Y; Oe M; Takai R; Suto H; Nagatani Y; Nishimura M; Imamura Y; Kunihisa T; Kiyota N; Miki K; Ohe K; Tanino H; Minami H
    Anticancer Res; 2022 Mar; 42(3):1199-1205. PubMed ID: 35220209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist.
    Prud'homme GJ; Glinka Y; Toulina A; Ace O; Subramaniam V; Jothy S
    PLoS One; 2010 Nov; 5(11):e13831. PubMed ID: 21072210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability.
    Croker AK; Goodale D; Chu J; Postenka C; Hedley BD; Hess DA; Allan AL
    J Cell Mol Med; 2009 Aug; 13(8B):2236-2252. PubMed ID: 18681906
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A subpopulation of CD24⁺ cells in colon cancer cell lines possess stem cell characteristics.
    Ke J; Wu X; Wu X; He X; Lian L; Zou Y; He X; Wang H; Luo Y; Wang L; Lan P
    Neoplasma; 2012; 59(3):282-8. PubMed ID: 22329848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WNT pathway inhibitor pyrvinium pamoate inhibits the self-renewal and metastasis of breast cancer stem cells.
    Xu L; Zhang L; Hu C; Liang S; Fei X; Yan N; Zhang Y; Zhang F
    Int J Oncol; 2016 Mar; 48(3):1175-86. PubMed ID: 26781188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial mass and DNA repair in breast cancer stem cells.
    Pestell RG; Fatatis A; Jiao X
    Oncotarget; 2015 Nov; 6(36):38442-3. PubMed ID: 26564961
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation therapy: targeting human renal cancer stem cells with interleukin 15.
    Azzi S; Bruno S; Giron-Michel J; Clay D; Devocelle A; Croce M; Ferrini S; Chouaib S; Vazquez A; Charpentier B; Camussi G; Azzarone B; Eid P
    J Natl Cancer Inst; 2011 Dec; 103(24):1884-98. PubMed ID: 22043039
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD133+ cancer stem cell-like cells derived from uterine carcinosarcoma (malignant mixed Müllerian tumor).
    Choijamts B; Jimi S; Kondo T; Naganuma Y; Matsumoto T; Kuroki M; Iwasaki H; Emoto M
    Stem Cells; 2011 Oct; 29(10):1485-95. PubMed ID: 21919130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malignant phyllodes tumors display mesenchymal stem cell features and aldehyde dehydrogenase/disialoganglioside identify their tumor stem cells.
    Lin JJ; Huang CS; Yu J; Liao GS; Lien HC; Hung JT; Lin RJ; Chou FP; Yeh KT; Yu AL
    Breast Cancer Res; 2014 Mar; 16(2):R29. PubMed ID: 24670249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
    Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
    Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.
    Skrbo N; Hjortland GO; Kristian A; Holm R; Nord S; Prasmickaite L; Engebraaten O; Mælandsmo GM; Sørlie T; Andersen K
    PLoS One; 2014; 9(11):e113278. PubMed ID: 25419568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer stem cell selectivity of synthetic nanomolar-active salinomycin analogs.
    Huang X; Borgström B; Kempengren S; Persson L; Hegardt C; Strand D; Oredsson S
    BMC Cancer; 2016 Feb; 16():145. PubMed ID: 26906175
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Hedgehog signalling pathway mediates drug response of MCF-7 mammosphere cells in breast cancer patients.
    He M; Fu Y; Yan Y; Xiao Q; Wu H; Yao W; Zhao H; Zhao L; Jiang Q; Yu Z; Jin F; Mi X; Wang E; Cui Z; Fu L; Chen J; Wei M
    Clin Sci (Lond); 2015 Nov; 129(9):809-22. PubMed ID: 26201092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.
    Wei W; Tweardy DJ; Zhang M; Zhang X; Landua J; Petrovic I; Bu W; Roarty K; Hilsenbeck SG; Rosen JM; Lewis MT
    Stem Cells; 2014 Oct; 32(10):2571-82. PubMed ID: 24891218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mitochondrial transplantation regulates antitumour activity, chemoresistance and mitochondrial dynamics in breast cancer.
    Chang JC; Chang HS; Wu YC; Cheng WL; Lin TT; Chang HJ; Kuo SJ; Chen ST; Liu CS
    J Exp Clin Cancer Res; 2019 Jan; 38(1):30. PubMed ID: 30674338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. BMP-2 inhibits tumor-initiating ability in human renal cancer stem cells and induces bone formation.
    Wang L; Park P; La Marca F; Than KD; Lin CY
    J Cancer Res Clin Oncol; 2015 Jun; 141(6):1013-24. PubMed ID: 25431339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrially targeted vitamin E succinate efficiently kills breast tumour-initiating cells in a complex II-dependent manner.
    Yan B; Stantic M; Zobalova R; Bezawork-Geleta A; Stapelberg M; Stursa J; Prokopova K; Dong L; Neuzil J
    BMC Cancer; 2015 May; 15():401. PubMed ID: 25967547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
    Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
    Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.